Abstract
Prostatic stromal tumor of uncertain malignant potential (STUMP), characterized by an atypical, unique stromal proliferation of the prostate, is often difficult to be differentiated from other nonepithelial neoplastic lesions. We present a unique case of recurrent STUMP after transurethral resection of the prostate (TURP) with concurrent prostatic adenocarcinoma. Patients diagnosed with prostatic STUMP should be followed up closely, for it may recur and invade adjacent organs after TURP shortly. Concurrent prostatic adenocarcinoma can be found in STUMP patients, and there may be some potential mechanisms which promote the simultaneous occurrence of the 2 tumors.
References
1.
Murer
LM
, Talmon
GA
. Stromal tumor of uncertain malignant potential of the prostate
. Arch Pathol Lab Med
. 2014
;138
(11
):1542
–5
.2.
Humphrey
PA
, Moch
H
, Cubilla
AL
, Ulbright
TM
, Reuter
VE
. The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours
. Eur Urol
. 2016
;70
(1
):106
–19
.3.
Klausner
AP
, Unger
P
, Fine
EM
. Recurrent prostatic stromal proliferation of uncertain malignant potential: a therapeutic challenge
. J Urol
. 2002
;168
:1493
–4
.4.
Bidikov
L
, Maroni
P
, Kim
S
, Crawford
ED
. 67-year-old male with prostatic stromal tumor of uncertain malignant potential
. Oncology
. 2019
;33
(9
):685007
.5.
Herawi
M
, Epstein
JI
. Specialized stromal tumors of the prostate: a clinicopathologic study of 50 cases
. Am J Surg Pathol
. 2006
;30
(6
):694
–704
.6.
Sadimin
ET
, Epstein
JI
. Round cell pattern of prostatic stromal tumor of uncertain malignant potential: a subtle newly recognized variant
. Hum pathol
. 2016
;52
:68
–73
.7.
Gaudin
PB
, Rosai
J
, Epstein
JI
. Sarcomas and related proliferative lesions of specialized prostatic stroma: a clinicopathologic study of 22 cases
. Am J Surg Pathol
. 1998
;22
(2
):148
–62
.8.
Muglia
VF
, Saber
G
, Maggioni
G
, Monteiro
AJ
. MRI findings of prostate stromal tumour of uncertain malignant potential: a case report
. Br J Radiol
. 2011
;84
(1006
):e194
–6
. .9.
Wee
HM
, Ho
SH
, Tan
PH
. Recurrent prostatic stromal tumour of uncertain malignant potential (STUMP) presenting with urinary retention 6 Years after transurethral resection of prostate (TURP)
. Ann Acad Med Singap
. 2005
;34
(7
):441
–2
.10.
De Berardinis
E
, Busetto
GM
, Antonini
G
, Giovannone
R
, Di Placido
M
, Magliocca
FM
, Incidental prostatic stromal tumor of uncertain malignant potential (STUMP): histopathological and immunohistochemical findings
. Urologia
. 2012
;79
(1
):65
–8
.11.
Nagar
M
, Epstein
JI
. Epithelial proliferations in prostatic stromal tumors of uncertain malignant potential (STUMP)
. Am J Surg Pathol
. 2011
;35
(6
):898
–903
.12.
Cunha
GR
, Hayward
SW
, Wang
YZ
, Ricke
WA
. Role of the stromal microenvironment in carcinogenesis of the prostate
. Int J Cance
. 2003
;107
(1
):1
–10
.13.
Liao
CP
, Adisetiyo
H
, Liang
M
, Roy-Burman
P
. Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells
. Cancer Res
. 2010
;70
(18
):7294
–303
.© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
